Share This Page
Drug Price Trends for ZOLPIDEM TART ER
✉ Email this page to a colleague

Average Pharmacy Cost for ZOLPIDEM TART ER
Drug Name | NDC | Price/Unit ($) | Unit | Date |
---|---|---|---|---|
ZOLPIDEM TART ER 12.5 MG TAB | 47335-0308-88 | 0.10873 | EACH | 2025-01-22 |
ZOLPIDEM TART ER 12.5 MG TAB | 10370-0116-10 | 0.10873 | EACH | 2025-01-22 |
ZOLPIDEM TART ER 12.5 MG TAB | 00955-1703-10 | 0.10873 | EACH | 2025-01-22 |
>Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Market Analysis and Price Projections for Zolpidem Tartrate Extended Release (ZOLPIDEM TART ER)
Market Overview
The market for Zolpidem Tartrate, particularly the extended-release formulations, is a significant segment within the pharmaceutical industry. This market is driven by the increasing prevalence of insomnia and other sleep-related disorders globally.
Market Size and Growth
The Zolpidem Tartrate market was valued at USD 1 billion in 2023 and is projected to reach USD 9.58 billion by 2031, growing at a Compound Annual Growth Rate (CAGR) of 8.2% from 2024 to 2031[1].
Key Drivers
Several factors are driving the growth of this market:
- Rising Prevalence of Insomnia: The increasing incidence of insomnia and other sleep disorders is a primary driver. As more people seek effective treatment options, the demand for Zolpidem Tartrate is rising[1][4].
- Advancements in Formulations: Improvements in patient compliance and efficacy due to extended-release and sublingual tablet formulations are enhancing the market. These advanced formulations address issues such as rapid onset and short duration of action, improving therapeutic outcomes[1][4].
- Growing Healthcare Infrastructure: The global expansion of healthcare infrastructure and increasing healthcare spending are making Zolpidem Tartrate more accessible, contributing to market growth[1].
- Awareness of Mental Health: Rising awareness of mental health and the importance of quality sleep are leading to more prescriptions and better diagnostic tools, further driving the market[1].
Market Segmentation
By Product Type
The market is segmented into various product types, including:
- Immediate-Release Tablets: These are the traditional form of Zolpidem Tartrate.
- Extended-Release Tablets: These formulations, such as Ambien CR, provide a longer duration of action and are gaining popularity due to their improved efficacy and patient compliance[3][4].
- Sublingual Tablets: These are designed for rapid absorption and are used for sleep initiation and maintenance[2].
By Distribution Channel
The distribution channels include:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
These channels play a crucial role in making Zolpidem Tartrate accessible to a wide range of patients[4].
By Region
The market is segmented geographically into:
- North America: A significant market due to high awareness and diagnosis of sleep disorders.
- Europe: Countries like Germany, France, and the UK contribute substantially to the European market.
- Asia-Pacific: Expected to witness the fastest growth due to increasing awareness and expanding healthcare sectors in countries like China, Japan, and India[4].
Price Projections
Extended-Release Tablets
The prices for Zolpidem Tartrate Extended Release (ER) tablets vary based on the dosage and quantity:
- 6.25 mg: Prices start from around $50.50 for 30 tablets, with costs ranging from $1.68 to $1.78 per unit[2][5].
- 12.5 mg: Prices start from around $24.40 for 30 tablets, with costs ranging from $0.81 to $1.61 per unit[2][5].
For a supply of 100 tablets, the cost can be as high as $2,271.99, depending on the pharmacy and availability[5].
Generic Versions
Generic versions of Ambien CR (Zolpidem Tartrate ER) are available, which can significantly reduce the cost for patients. For example, Breckenridge Pharmaceutical's generic version is marketed at competitive prices, contributing to the affordability and accessibility of the drug[3].
Competitive Landscape
The market for Zolpidem Tartrate is highly competitive, with several major players investing in research and development to maintain their market position and introduce new products. Companies like Breckenridge Pharmaceutical and Centaur Pharmaceuticals are key players, offering generic and innovative formulations[1][3][4].
Future Outlook
The Zolpidem Tartrate market is expected to experience sustained growth over the next few years. Here are some key points:
- Increasing Demand: The demand for effective sleep aids will continue to rise due to lifestyle changes and increased stress levels.
- Innovative Formulations: The development of extended-release and sublingual formulations will continue to drive market growth.
- Expansion into Emerging Markets: The Asia-Pacific region and other emerging markets will see significant growth due to increasing awareness and diagnosis of sleep disorders[4].
"The market for zolpidem tartrate is expanding significantly due to the increased incidence of insomnia and other sleep disorders around the world. The industry is being driven further by rising awareness of mental health and an ageing population that is more likely to have sleep-related problems."[1]
Key Takeaways
- The Zolpidem Tartrate market is projected to grow significantly, driven by the rising prevalence of insomnia and advancements in formulations.
- Extended-release and sublingual tablets are gaining popularity due to improved efficacy and patient compliance.
- The market is highly competitive, with major players focusing on R&D and expanding into emerging markets.
- Generic versions are making the drug more affordable and accessible.
FAQs
What is Zolpidem Tartrate used for?
Zolpidem Tartrate is used to treat insomnia and other sleep-related disorders. It is a non-benzodiazepine hypnotic agent that helps in sleep initiation and maintenance.
What are the different formulations of Zolpidem Tartrate?
Zolpidem Tartrate is available in various formulations, including immediate-release tablets, extended-release tablets, and sublingual tablets.
How much does Zolpidem Tartrate Extended Release cost?
The cost of Zolpidem Tartrate Extended Release can vary, but it starts from around $50.50 for 30 tablets of the 6.25 mg strength and $24.40 for 30 tablets of the 12.5 mg strength.
What are the key drivers of the Zolpidem Tartrate market?
The key drivers include the rising prevalence of insomnia, advancements in formulations, growing healthcare infrastructure, and increasing awareness of mental health.
Which regions are expected to see the fastest growth in the Zolpidem Tartrate market?
The Asia-Pacific region is expected to witness the fastest growth due to increasing awareness and expanding healthcare sectors in countries like China, Japan, and India.
Are generic versions of Zolpidem Tartrate available?
Yes, generic versions of Zolpidem Tartrate, including extended-release formulations, are available and can be more affordable than brand-name versions.
Sources
- Market Research Intellect: Zolpidem Tartrate Market Size, Share | Industry Research Report 2031
- Drugs.com: Zolpidem Prices, Coupons, Copay Cards & Patient Assistance
- PR Newswire: Breckenridge Pharmaceutical, Inc. Announces Launch of Zolpidem Tartrate Extended-Release Tablets, USP (generic for Ambien CR)
- Data Horizon Research: Zolpidem Tartrate Tablets Market Size, Share, Growth, Statistics
- Drugs.com: Ambien CR Prices, Coupons, Copay Cards & Patient Assistance
More… ↓